A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system

First identified as the etiological agent behind Acquired Immunodeficiency Syndrome (AIDS) in the early 1980s, HIV-1 has continued to spread into a global pandemic and major public health concern. Despite the success of antiretroviral therapy at reducing HIV-1 viremia and preventing the dramatic CD4...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:NPJ Vaccines
Main Authors: Pankrac, Joshua, Klein, Katja, McKay, Paul F., King, Deborah F. L., Bain, Katie, Knapp, Jason, Biru, Tsigereda, Wijewardhana, Chanuka N., Pawa, Rahul, Canaday, David H., Gao, Yong, Fidler, Sarah, Shattock, Robin J., Arts, Eric J., Mann, Jamie F. S.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5775397/
https://ncbi.nlm.nih.gov/pubmed/29367885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-017-0040-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados